Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AmpSource Bio is a biotechnology company specializing in the discovery, design, and production of antimicrobial peptides (AMPs). The company utilizes a proprietary AI-driven platform combined with high-throughput screening technologies to identify and optimize novel peptide candidates with high efficacy and low toxicity. AmpSource Bio provides a range of services including custom peptide synthesis, library construction, and functional screening for applications in human health, animal nutrition, and agriculture. Their technology aims to address the global challenge of antimicrobial resistance by providing next-generation alternatives to traditional antibiotics. By leveraging computational biology and advanced manufacturing, the company accelerates the development of sustainable peptide-based solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ampsourcebio.